Cargando…

Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR

Triple-negative breast cancer (TNBC) does not express conventional therapeutic targets and is the only type of malignant breast cancer for which no designated FDA-approved targeted therapy is available. Although overexpression of epidermal growth factor receptor (EGFR) is frequently found in TNBC, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuan-Liang, Overstreet, Anne-Marie, Chen, Min-Shan, Wang, Jiang, Zhao, Hua-Jun, Ho, Po-Chun, Smith, Molly, Wang, Shao-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484446/ https://www.ncbi.nlm.nih.gov/pubmed/25883211

Ejemplares similares

Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
por: Shen, Jia, et al.
Publicado: (2018)

Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides
por: Yu, Yung-Luen, et al.
Publicado: (2013)

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
por: Bieerkehazhi, Shayahati, et al.
Publicado: (2016)

Dioscin inhibits gastric tumor growth through regulating the expression level of lncRNA HOTAIR
por: Ma, Ting, et al.
Publicado: (2016)

Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer
por: Zhang, Qian-Qian, et al.
Publicado: (2017)

Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
por: He, Qing, et al.
Publicado: (2016)

Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
por: Hu, Xueyi, et al.
Publicado: (2023)

Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
por: He, Qing, et al.
Publicado: (2017)

Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
por: Inoue, Satoshi, et al.
Publicado: (2012)

Growth-promoting function of the cGAS-STING pathway in triple-negative breast cancer cells
por: Liu, Liang-Chih, et al.
Publicado: (2022)

Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4
por: Wang, Ying, et al.
Publicado: (2020)

Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China
por: Cao, Wen-Ming, et al.
Publicado: (2015)

Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis
por: Gupta, Nehal, et al.
Publicado: (2021)

Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
por: Camorani, Simona, et al.
Publicado: (2017)

TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression
por: Bi, Jing, et al.
Publicado: (2023)

Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer
por: Byun, Woong Sub, et al.
Publicado: (2020)

Osthole inhibits triple negative breast cancer cells by suppressing STAT3
por: Dai, Xuanxuan, et al.
Publicado: (2018)

Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1
por: Maharjan, Sony, et al.
Publicado: (2018)

Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb‐E2F signaling and epithelial‐mesenchymal transition
por: Wang, Weilin, et al.
Publicado: (2020)

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
por: Hou, Lingmi, et al.
Publicado: (2016)

MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells
por: Zhang, Guochen, et al.
Publicado: (2020)

CAPE-pNO(2) Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway
por: Huang, Qin, et al.
Publicado: (2019)

Abl Is Able to Inhibit Cell Engulfment
por: Robinson, Richard
Publicado: (2009)

Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
por: Yao, Nan, et al.
Publicado: (2020)

Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells
por: Gupta, Nehal, et al.
Publicado: (2021)

microRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2
por: Zhang, Gaolian, et al.
Publicado: (2021)

ABL Tyrosine Kinase Inhibition Variable Effects on the Invasive Properties of Different Triple Negative Breast Cancer Cell Lines
por: Chevalier, Clément, et al.
Publicado: (2015)

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
por: Barzegar, Mansoureh, et al.
Publicado: (2017)

Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
por: Rajput, Sandeep, et al.
Publicado: (2016)

Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer
por: Li, Ting, et al.
Publicado: (2021)

Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer
por: Cao, Yi, et al.
Publicado: (2023)

ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells
por: Yuan, Xun, et al.
Publicado: (2017)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
por: Wu, Qin, et al.
Publicado: (2020)

Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide
por: Arumugam, Arunkumar, et al.
Publicado: (2021)

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
por: Salerno, Dominick, et al.
Publicado: (2021)

Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
por: Saraiva, Sofia M., et al.
Publicado: (2021)

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
por: You, Kyu Sic, et al.
Publicado: (2021)

Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
por: Zhao, Hongting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eodpodbor41b9pnaid8fq5vro8